Core Biogenesis

company

About

Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$11M
Industries
Biotechnology,Life Science,Pharmaceutical
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active

Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies. The company uses proprietary gene editing and plant biotechnology to drastically reduce the cost of making growth factors. The growth factors are molecules used in the clean meat and cell therapy industries.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$11M
Core Biogenesis has raised a total of $11M in funding over 2 rounds. Their latest funding was raised on Mar 30, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 30, 2022 Series A $11M 1 Blue Horizon Equity Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Core Biogenesis is funded by 1 investors. Blue Horizon Equity are the most recent investors.
Investor Name Lead Investor Funding Round
Blue Horizon Equity Yes Series A